Filter Results:
(123)
Show Results For
- All HBS Web (123)
- Faculty Publications (10)
Show Results For
- All HBS Web (123)
- Faculty Publications (10)
- 27 Feb 2018
- First Look
First Look at New Research and Ideas, February 27, 2018
company. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/718403-PDF-ENG Harvard Business School Case 618-033 BeiGene BeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges... View Details
Keywords: Sean Silverthorne
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
in the diabetic space, became MannKind’s marketing partner and helped launch Afrezza in February, 2015. Although the drug had a black box warning and required doctors to perform a lung test on patients, expectations were high, with some... View Details
Keywords: Sean Silverthorne
- 19 Dec 2017
- First Look
New Research and Ideas, December 19, 2017
Abstract—No abstract available. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=53633 Characterizing the Drug Development Pipeline for Precision Medicines By: Chandra, Amitabh, Craig Garthwaite, and Ariel Dora Stern... View Details
Keywords: Carmen Nobel
- 08 Jun 2010
- First Look
First Look: June 8
case:http://cb.hbsp.harvard.edu/cb/product/810123-PDF-ENG Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration Karim R. Lakhani and Paul R. CarlileHarvard Business School Case 610-074 This case presents the Myelin... View Details
Keywords: Martha Lagace
- Research Summary
Clinical Trials as a setting for Health Policy and Management Research
The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details
- 26 Feb 2019
- First Look
New Research and Ideas, February 26, 2019
Howard, Sara J. Singer, and Amy C. Edmondson Abstract— For too long, the worlds of business and health have been mired in a checkered, sometimes contentious, history. Millions of deaths worldwide can be attributed to risk factors including tobacco use, alcohol and... View Details
Keywords: Dina Gerdeman
- 12 Feb 2019
- First Look
New Research and Ideas, February 12, 2019
Devices: Challenges and Opportunities for U.S. Regulators and Innovators By: Gordon, William J., and Ariel Dora Stern Abstract— Software has become an increasingly important component of medical device technology. Through legislation like the 21st Century Cures Act as... View Details
Keywords: Dina Gerdeman
- 18 Apr 2018
- First Look
First Look at New Research and Ideas, April 18, 2018
organization among enterprises specializing in overseas ventures, they did not become the dominant form of large enterprises within British economy itself. Business groups organized under the holding company such as Calico Printers'... View Details
Keywords: Sean Silverthorne
- 25 Sep 2018
- First Look
New Research and Ideas, September 25, 2018
operations. Product failures are, therefore, likely to impact firms’ subsequent innovation activities. Using 13 years of Food and Drug Administration data, we examine the effects of firm and competitor medical device recalls on subsequent... View Details
Keywords: Dina Gerdeman
- 24 Apr 2018
- First Look
First Look at New Research and Ideas, April 24, 2018
Tella, and Lucas Llach Abstract—This article is an introduction to the special collection on Argentine Exceptionalism. First, we discuss why the case of Argentina is generally regarded as exceptional: the country was among the richest in... View Details
Keywords: Sean Silverthorne
- Web
Skydeck - Alumni
We’re All Going to Get Hacked Companies shouldn’t just react to the inevitable hack, says Red Seal CEO Ray Rothrock (MBA 1988) —they should prepare for it. The Promise of Personalized Medicine Rich Horgan (MBA 2018) is on an urgent mission to save his brother—and he... View Details
- 23 Oct 2018
- First Look
New Research and Ideas, October 23, 2018
media to engage others and build campaigns for change in the company. This case follows her career at the company and describes the challenges she faced as a change agent, working to promote gender equality within the company and a new View Details
Keywords: Dina Gerdeman
- 26 Aug 2024
- Blog Post
HBS Lingo 101
change careers after HBS, and CPD works to help each student define their own unique career vision. The CPD team includes over 50 career coaches who specialize in different industries, geographies or life stages. CPD partners with over... View Details
- 27 Feb 2019
- Research & Ideas
The Hidden Cost of a Product Recall
Evidence from Medical Device Firms, released in January. Bigger recalls, bigger reactions Using 13 years of US Food and Drug Administration data and a novel set of competitor classification algorithms, the team created a detailed history... View Details
- Web
Faculty & Advisors - MBA
Chairman of Blink Health LLC, an e-commerce platform providing access to prescription drugs for all Americans. Bill is also the lead independent director of Minerva Neuroscience and a director of Optinose, Inc. Previously, Bill was a... View Details
- Web
Past Issues - Alumni
HBS faculty and alumni offer nine strategies to put you over the top, whatever the year ahead may hold. Out of the Valley A special Skydeck miniseries explores how frontier markets are defining the future of innovation In Review Nitin... View Details
- 21 Aug 2018
- First Look
New Research and Ideas, August 21, 2018
growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby largely... View Details
Keywords: Dina Gerdeman
- 26 Jan 2015
- Research & Ideas
National Health Costs Could Decrease if Managers Reduce Work Stress
Mortality and Health Costs in the United States, written with Stanford business professors Jeffrey Pfeffer and Stefanos A. Zenios. Goh specializes in developing complex mathematical models that can aid decision making, especially in the... View Details
- 12 Dec 2005
- Research & Ideas
Using the Law to Strategic Advantage
create value and manage risk. Q: Most managers don't have law degrees, so who do they turn to get the legal background they will need to work with legal staff on the issues you identify? Will they need special training? A: I like to think... View Details
- 13 Jul 2020
- Research & Ideas
Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk
gives away a drug called Mectizan for river blindness. That's one pill per person per year. And we found it's really hard to get that the last mile to the people who really need it. Okay? So I would say there are two big issues with... View Details